drug
TSRA-196
Phase 2updated 5mo agoby Tessera Therapeutics Inc
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying TSRA-196
News(2)
- Novo workforce down 13,000Follow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 5d ago
- Chutes & Ladders—Legend CEO departs without successor in placeLegend Biotech CEO Ying Huang, Ph.D., has left the company suddenly, without a predecessor in place. Huang was elevated from CFO to CEO in 2020 after a Chinese customs investigation was opened on f…fiercebiotech · 1mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that